Targeted apoptosis of senescent cells by valproic acid alleviates therapy-induced cellular senescence and lung aging.

Wentao Sun, Yue Gao, Yubing Wu, Wei Wu, Chaofan Wang, JiaXiao Chen, Changjiao Luan, Ming Hua, Weili Liu, Weijuan Gong, Xingjie Ma

Laboratory of Intensive Care, Department of Intensive Care, The Affiliated Hospital of Yangzhou University, Yangzhou, PR China. · pubmed

Paper

Abstract

Accumulation of senescent cells in tissues and their downstream effect programs have emerged as key drivers of aging and age-associated pathologies. Recent progresses in senotherapeutics indicated that either selectively killing senescent cells with senolytics or suppressing the senescence-associated secretory phenotype (SASP) secretion using senomorphics contributes to extending of the healthy lifespan and alleviating numerous age-related disorders in mice.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper addresses the targeted apoptosis of senescent cells, which is directly related to the mechanisms of aging and the potential for lifespan extension through senotherapeutics. While the findings contribute to the understanding of cellular senescence and its implications for aging, the research appears to be a solid advancement rather than a groundbreaking discovery, thus earning a moderate impact score.

Author of this paper? Send a correction.